Simultaneous determination of the histamine H1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography
| Autor: | Yasuyuki Mizuki, Yoshiaki Terauchi, Michiaki Matsuda |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Ebastine
Chromatography Metabolite Extraction (chemistry) Reproducibility of Results General Chemistry Histamine H1 receptor Butyrophenones Sensitivity and Specificity High-performance liquid chromatography chemistry.chemical_compound Piperidines chemistry Pharmacokinetics Antiallergic agent Histamine H1 Antagonists medicine Humans Ammonium acetate Chromatography High Pressure Liquid medicine.drug |
| Zdroj: | Journal of Chromatography B: Biomedical Sciences and Applications. 757:173-179 |
| ISSN: | 0378-4347 |
| DOI: | 10.1016/s0378-4347(00)00494-1 |
| Popis: | Ebastine (CAS 90729-43-4) is an antiallergic agent which selectively and potently blocks histamine H1-receptors in vivo. A simple and sensitive high-performance liquid chromatography (HPLC) method is described for the simultaneous determination of ebastine and its two oxidized metabolites, carebastine (CAS 90729-42-3) and hydroxyebastine (M-OH), in human plasma. After a pretreatment of plasma sample by solid-phase extraction, ebastine and its metabolites were analyzed on an HPLC system with ultraviolet detection at 254 nm. Chromatography was performed on a cyano column (250x4.0 mm I.D.) at 40 degrees C with the mobile phase of acetonitrile-methanol-0.012 M ammonium acetate buffer (20:30:48, v/v/v) at a flow rate of 1.2 ml/min. Accurate determinations were possible over the concentration range of 3-1000 ng/ml for the three compounds using 1 ml plasma samples. The intra- and inter-day assay accuracy of this method were within 100+/-15% of nominal values and the precision did not exceed 12.4% of relative standard deviation. The lower limits of quantitation were 3 ng/ml for ebastine and its metabolites in human plasma. This method was satisfactorily applied to the determination of ebastine and its two oxidized metabolites in human plasma after oral administration of ebastine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|